Cellectar Biosciences Inc. is a clinical-stage biopharmaceutical company that develops innovative cancer therapies. With its proprietary phospholipid drug conjugate platform, the company aims to target and eradicate various types of cancer cells while sparing healthy ones. Their cutting-edge approach has the potential to revolutionize cancer treatment and save countless lives.
Notification